Value Creation Process
Following our corporate philosophy that states “Kyorin continues to fulfill its mission of cherishing life and benefiting society by contributing to better health,” the Kyorin Group is carrying out business activities aligned with our newly formulated long-term vision, medium-term business plan, and designated materialities (important issues).
With a new drugs business that continuously provides high-value new drugs to meet diverse medical needs as our core business, we are comprehensively developing health-related businesses to realize corporate growth and address social issues, while also striving to create value by sharing the successes of those efforts with all stakeholders.
Through this ongoing value creation process, we aim to achieve a sustainable society and enhance corporate value.
